Co-Authors
This is a "connection" page, showing publications co-authored by Sonia Burrel and Vincent Calvez.
Connection Strength
1.204
-
Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value. Clin Microbiol Infect. 2021 07; 27(7):1056-1057.
Score: 0.232
-
Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19. Int J Infect Dis. 2021 Jan; 102:10-13.
Score: 0.227
-
Medical features of COVID-19 and influenza infection: A comparative study in Paris, France. J Infect. 2021 02; 82(2):e36-e39.
Score: 0.224
-
Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital. Clin Infect Dis. 2021 12 06; 73(11):e4064-e4072.
Score: 0.061
-
Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers. Clin Infect Dis. 2021 May 29.
Score: 0.059
-
Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun. 2021 May 10; 12(1):2824.
Score: 0.059
-
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J Infect. 2021 Jul; 83(1):119-145.
Score: 0.059
-
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun. 2021 02 08; 12(1):844.
Score: 0.058
-
The First Locally Acquired Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Healthcare Worker in the Paris Area. Clin Infect Dis. 2020 12 03; 71(9):e530-e531.
Score: 0.057
-
Evolution of viral quasispecies during SARS-CoV-2 infection. Clin Microbiol Infect. 2020 Nov; 26(11):1560.e1-1560.e4.
Score: 0.056
-
Clinical presentation of Covid-19 in health care workers from a French University Hospital. J Infect. 2020 09; 81(3):e61-e63.
Score: 0.056
-
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19. J Infect. 2021 01; 82(1):159-198.
Score: 0.055